Soft-Tissue Sarcoma

Chapter

Abstract

This chapter will discuss staging and management of soft tissue sarcomas with focus on radiotherapy studies and techniques.

Keywords

Soft tissue sarcoma Radiotherapy Brachytherapy 

Notes

Acknowledgments

We thank Brian Lee MD, PhD and Stuart Y. Tsuji MD, PhD for their work on the prior edition of this chapter.

References

  1. Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24:257–63.CrossRefGoogle Scholar
  2. Alamanda VK, Crosby SN, Archer KR, et al. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol. 2013;52:793–802.CrossRefGoogle Scholar
  3. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000;47:157–63.CrossRefGoogle Scholar
  4. Davis AM, O’Sullivan B, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.CrossRefGoogle Scholar
  5. Dhakal S, et al. Stereotactic body radiotherapy for pulmonary metastases from soft tissue sarcomes: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys. 2012;82(2):940–5.CrossRefGoogle Scholar
  6. Dickie CI, Parent AL, et al. Bone fractures following EBRT an limb preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. IJROBP. 2009;75(4):1119–24.Google Scholar
  7. Dickson MA, Tap WD, Keohan ML, et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well- differentiated or dedifferentiated liposarcoma. J Clin Oncol. 2013;31(16):2024–8.CrossRefGoogle Scholar
  8. Ferguson PC, Deheshi BM, Chung P, et al. Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection. Cancer. 2011;117:372–9.CrossRefGoogle Scholar
  9. Folkert M, Bilsky M, et al. Outcomes and toxicity or hypofractionated and singe fraction image guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys. 2014a;88(5):1085–91.CrossRefGoogle Scholar
  10. Folkert M, Singer S, et al. Comparison of local recurrence with conventional and IMRT for primary soft tissue sarcomas of the extremity. J Clin Oncol. 2014b;32(29):3236–41.CrossRefGoogle Scholar
  11. Italiano A, Delva F, et al. Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann Oncol. 2010;21(12):2436–41.CrossRefGoogle Scholar
  12. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104:669–75.CrossRefGoogle Scholar
  13. Nussbaum D, Rushing C, et al. Preoperative or postoperative radiotherapy vs surgery alone for retroperitoneal sarcoma: a case control, propensity score matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17(7):966–75.CrossRefGoogle Scholar
  14. O’Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235–41.CrossRefGoogle Scholar
  15. O’Sullivan B, Chung P, Euler C, et al. Soft tissue sarcoma. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed. Philadelphia: Elsevier; 2007. p. 1519–49.Google Scholar
  16. Oertel S, Treiber M, Zahlten-Hinguranage A, et al. Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2006;64:1416–23.CrossRefGoogle Scholar
  17. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized Resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.CrossRefGoogle Scholar
  18. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859–68.CrossRefGoogle Scholar
  19. Pollack A, Zagars GK, Goswitz MS, et al. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys. 1998;42:563–72.CrossRefGoogle Scholar
  20. Robinson MH, Gaunt P, et al. Vortex trial : a randomized controlled multicenter phase 3 trial of volume of postoperative radiation therapy given to adult patients with extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2016;96(2):S1.CrossRefGoogle Scholar
  21. Roeder F, Lehner B, et al. Excellent local control with IORT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prostpective trial. BMC Cancer. 2014;14:350.CrossRefGoogle Scholar
  22. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128:402–10.CrossRefGoogle Scholar
  23. Tinkle C, Weinberg V, et al. Intraoperative radiotherapy in the management of locally recurrent extremity soft tissue sarcoma. Sarcoma. 2015;2015(3):1–8. 913565CrossRefGoogle Scholar
  24. van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double- blind, placebo-controlled phase 3 trial. Lancet. 2012;379:1879–86.CrossRefGoogle Scholar
  25. Wang D, Burton LE, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with IGRT to a reduced target volume: results of RTOG 0630 trial. J Clin Oncol. 2015;33(20):2231–8.CrossRefGoogle Scholar
  26. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations